黄山胶囊(002817) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥93,656,298.81, representing a 13.10% increase year-over-year[5] - Net profit attributable to shareholders for the same period was ¥16,583,398.01, up by 3.32% compared to the previous year[5] - Total operating revenue for the third quarter of 2022 was CNY 301,178,173.56, an increase of 8.3% compared to CNY 278,105,057.36 in the same period last year[39] - Net profit for the third quarter reached CNY 48,220,190.73, representing a 16.5% increase from CNY 41,406,384.94 in the previous year[40] - Earnings per share (EPS) for the quarter was CNY 0.16, compared to CNY 0.14 in the same quarter last year, indicating a growth of 14.3%[40] - The total equity attributable to shareholders of the parent company was CNY 840,944,224.34, up from CNY 809,694,572.19, reflecting a growth of 3.9%[39] - The total comprehensive income for the quarter was CNY 48,522,337.05, an increase from CNY 41,496,818.78, representing a growth of 17.3%[40] Cash Flow - The operating cash flow net amount for the year-to-date period reached ¥67,058,100.52, showing a significant increase of 111.46%[5] - The net cash flow from operating activities increased by ¥35,345,400, a growth of 111.46%, attributed to higher cash receipts from sales[29] - The net cash flow from operating activities for the period was ¥67,058,100.52, an increase of 111.1% compared to ¥31,712,693.40 in the previous period[41] - Total cash inflow from investment activities was ¥453,876,802.98, significantly higher than ¥5,458,760.93 in the previous period[41] - The net cash flow from investment activities was -¥246,780,048.91, worsening from -¥63,490,876.00 in the previous period[41] - Cash flow from financing activities resulted in a net outflow of -¥22,234,805.05, compared to a net inflow of ¥39,251,572.00 in the previous period[42] - The total cash and cash equivalents at the end of the period stood at ¥142,238,131.71, down from ¥248,958,363.80 at the end of the previous period[42] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,093,508,453.78, reflecting a 3.77% increase from the end of the previous year[5] - The total liabilities increased to CNY 252,101,974.12 from CNY 243,844,826.99, marking a rise of 3.1%[39] - The company’s non-current liabilities decreased to CNY 93,153,737.79 from CNY 97,947,796.63, a decline of 5.0%[39] - The company’s non-current assets total RMB 422,465,387.55 as of September 30, 2022, slightly up from RMB 414,167,687.10 at the beginning of the year[36] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,622[31] - The largest shareholder, Yu Chunming, holds 38.05% of shares, totaling 113,802,815 shares, with 37,020,000 shares pledged[31] Investments and Expenses - The company reported a 116.08% increase in trading financial assets, amounting to ¥75,617,300, primarily due to investments in bank wealth management products[9] - Research and development expenses for the quarter were CNY 10,418,005.92, slightly down from CNY 11,284,663.73, indicating a decrease of 7.7%[39] - The company reported a financial income of CNY 4,837,532.59, compared to CNY 5,366,642.46 in the previous year, showing a decline of 9.9%[39] Inventory and Receivables - The company’s inventory as of September 30, 2022, is RMB 115,712,327.43, up from RMB 90,742,292.83 at the beginning of the year[36] - The company reported accounts receivable of RMB 103,197,011.65 as of September 30, 2022, an increase from RMB 80,999,747.90 at the beginning of the year[36]